Clinical trial

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to…

NCT00427297 · University of Washington, Other · Terminated

Key facts

NCT number NCT00427297
Title Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya
Official title Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya (6-12 Month RCT)
Lead sponsor University of Washington, Other
Collaborators Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH
Status Terminated
Phase Phase 3
Study type Interventional
Conditions HIV Infections
Intervention type Drug
Interventions AZT/3TC/NVP (zidovudine/lamivudine/nevirapine), d4T/3TC/NVP (stavudine/lamivudine/nevirapine), AZT/3TC/ABC (zidovudine/lamivudine/abacavir), d4T/3TC/ABC (stavudine/lamivudine/abacavir), ddI/ABC/LPV/r (didanosine/abacavir/lopinavir-ritonavir), ABC/ ddI or TDF / NVP or EFV (abacavir / didanosine or tenofovir / nevirapine or efavirenz), ABC/3TC/NVP (abacavir/lamivudine/nevirapine)
Enrollment 34
Start date Sep 1, 2007
Primary completion May 1, 2009
Completion Dec 1, 2009
First posted Jan 29, 2007
Last update posted Aug 27, 2018
Countries Kenya

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies